Wednesday, February 10, 2010, 5:49pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Response Genetics, Inc (RGDX)

At 4:21AM SGT: 1.3199 USD   0.00 (0.00%)  
 MORE ON RGDX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Response Genetics, Inc. (NCM:RGDX) Delayed quote dataEdit
Last Trade:1.3199 USD
Trade Time:4:21AM SGT
Change: 0.00 (0.00%)
Prev Close:1.3199
Open:N/A
Bid:1.19 x 500
Ask:N/A
1y Target Est:3.00
Day's Range:N/A - N/A
52wk Range:0.29 - 2.72
Volume:0
Avg Vol (3m):8,587.3
Market Cap:20.19M
P/E (ttm):N/A
EPS (ttm):-0.917
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add RGDX to Portfolio   Download Data

 HEADLINES 
•RESPONSE GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed 6:09am)
•Response Genetics to Present at the 20th Annual UBS Global Healthcare Services Conference and at the 12th Annual BIO CEO & Investor Conference
Business Wire (Thu, Feb 4)
•Response Genetics Announces Appointment of Dr. Edith P. Mitchell to Board of Directors
Business Wire (Wed, Jan 20)
•RESPONSE GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
EDGAR Online (Wed, Jan 20)
•Response Genetics to Increase Sales Force by 50 percent to Meet Growing Demand for its ResponseDX Tests
Business Wire (Mon, Jan 11)
•Response Genetics Inc. Announces Distribution Agreement with Genetic Technologies Ltd. to Expand the Availability of ResponseDX Molecular Diagnostic Tests Internationally
Business Wire (Wed, Jan 6)
•RESPONSE GENETICS INC Financials
EDGAR Online Financials (Sat, Nov 21)
•RESPONSE GENETICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 17)
•Response Genetics, Inc. Reports Third Quarter 2009 Financial Results Driven by 100 Percent Increase in ResponseDX Revenues
Business Wire (Tue, Nov 17)
•Q3 2009 RESPONSE GENETICS INC Earnings Release - After Market Close
CCBN (Mon, Nov 16)
More Headlines for RGDX...
 ANALYST 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Response Genetics, Inc., a life sciences company, engages in the research, development, marketing, and sale of clinical diagnostics and pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and Japan.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices